Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 30
-Paragraph 8
-SubTopic 30
-Topic 805
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479637/805-30-30-8

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)
-SubTopic 30
-Topic 805
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479581/805-30-50-1

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 30
-Paragraph 7
-SubTopic 30
-Topic 805
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479637/805-30-30-7

Name:	us-gaap_BusinessCombinationConsiderationTransferred1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Organization and Business (Details) $ in Millions	1 Months Ended	9 Months Ended
Organization and Business (Details) $ in Millions	Oct. 31, 2020 USD ($) ft²	Sep. 30, 2024 numberOfLicensedCompound inhibitor	Oct. 23, 2020 ft²
Business Acquisition [Line Items]
Number of licensed compounds \| numberOfLicensedCompound		2
Number of inhibitors \| inhibitor		2
CPM
Business Acquisition [Line Items]
Total consideration \| $	$ 2.5
CPM \| Old Bridge New Jersey
Business Acquisition [Line Items]
Area of real estate property (sq. ft.) \| ft²	4,000		4,000